Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

INVOLVEMENT OF INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR α IN CYP3A11 AND 2C29 DOWN-REGULATION BY BACILLUS CALMETTE-GUÉRIN AND LIPOPOLYSACCHARIDE IN MOUSE LIVER

Takashi Ashino, Takiko Oguro, Seiji Shioda, Reiko Horai, Masahide Asano, Kenji Sekikawa, Yoichiro Iwakura, Satoshi Numazawa and Takemi Yoshida
Drug Metabolism and Disposition July 2004, 32 (7) 707-714; DOI: https://doi.org/10.1124/dmd.32.7.707
Takashi Ashino
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takiko Oguro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seiji Shioda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reiko Horai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masahide Asano
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenji Sekikawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoichiro Iwakura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satoshi Numazawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takemi Yoshida
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 32 no. 7 707-714
DOI 
https://doi.org/10.1124/dmd.32.7.707
PubMed 
15205385

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received December 12, 2003
  • Accepted March 23, 2004
  • Published online June 17, 2004.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Takashi Ashino,
  2. Takiko Oguro,
  3. Seiji Shioda,
  4. Reiko Horai,
  5. Masahide Asano,
  6. Kenji Sekikawa,
  7. Yoichiro Iwakura,
  8. Satoshi Numazawa and
  9. Takemi Yoshida
  1. Department of Biochemical Toxicology, School of Pharmaceutical Sciences, Showa University, Tokyo, Japan (T.A., S.N., T.Y); Japan Development, R&D Alcon Research, Ltd., Fort Worth, Texas (T.O.); Department of Anatomy, School of Medicine, Showa University, Tokyo, Japan (S.S.); Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan (R.H., Y.I.); Department of Transgenic Animal Science, Graduate School of Medical Science, Kanazawa University, Ishikawa, Japan (M.A.); and Department of Molecular Biology and Immunology, National Institute of Agrobiological Sciences, Ibaraki, Japan (K.S.)
  1. Address correspondence to:
    Takemi Yoshida, Department of Biochemical Toxicology, School of Pharmaceutical Sciences, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555. E-mail: yoshida{at}pharm.showa-u.ac.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 20173113
Sep 20172186
Oct 20171227
Nov 20170225
Dec 20170179
Jan 20180147
Feb 20180144
Mar 20180216
Apr 20180214
May 20180263
Jun 20180197
Jul 20180152
Aug 20180121
Sep 20180120
Oct 2018061
Nov 20180182
Dec 2018753
Jan 2019540
Feb 20192233
Mar 20191740
Apr 20192070
May 2019900
Jun 2019414
Jul 2019721
Aug 20192420
Oct 20192000
Nov 20191510
Dec 20191421
Jan 20201430
Feb 20201000
Mar 2020200
May 2020333
Jun 2020600
Jul 2020500
Aug 2020700
Sep 2020821
Oct 20201811
Nov 20201510
Dec 20201300
Jan 20211481
Feb 202115142
Mar 20211732
Apr 20211321
May 2021871
Jun 20211850
Jul 2021920
Aug 2021980
Sep 2021520
Oct 20211520
Nov 20211841
Dec 20212941
Jan 2022721
Feb 2022610
Mar 2022721
Apr 20221580
May 20221110
Jun 2022930
Jul 20221121
Aug 20221740
Sep 20221730
Oct 20222170
Nov 20221410
Dec 20222720
Jan 20232230
Feb 2023630
Mar 20231820

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 32 (7)
Drug Metabolism and Disposition
Vol. 32, Issue 7
1 Jul 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
INVOLVEMENT OF INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR α IN CYP3A11 AND 2C29 DOWN-REGULATION BY BACILLUS CALMETTE-GUÉRIN AND LIPOPOLYSACCHARIDE IN MOUSE LIVER
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

INVOLVEMENT OF INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR α IN CYP3A11 AND 2C29 DOWN-REGULATION BY BACILLUS CALMETTE-GUÉRIN AND LIPOPOLYSACCHARIDE IN MOUSE LIVER

Takashi Ashino, Takiko Oguro, Seiji Shioda, Reiko Horai, Masahide Asano, Kenji Sekikawa, Yoichiro Iwakura, Satoshi Numazawa and Takemi Yoshida
Drug Metabolism and Disposition July 1, 2004, 32 (7) 707-714; DOI: https://doi.org/10.1124/dmd.32.7.707

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

INVOLVEMENT OF INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR α IN CYP3A11 AND 2C29 DOWN-REGULATION BY BACILLUS CALMETTE-GUÉRIN AND LIPOPOLYSACCHARIDE IN MOUSE LIVER

Takashi Ashino, Takiko Oguro, Seiji Shioda, Reiko Horai, Masahide Asano, Kenji Sekikawa, Yoichiro Iwakura, Satoshi Numazawa and Takemi Yoshida
Drug Metabolism and Disposition July 1, 2004, 32 (7) 707-714; DOI: https://doi.org/10.1124/dmd.32.7.707
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mass Balance Recovery and Disposition of AZD4831 in Humans
  • Biotransformation of AZD4831 in Animals and Humans
  • AKRs and GUSs in Testosterone Disposition
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics